BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34522163)

  • 1. Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses.
    Lee CL; Lee KS; Chuang CK; Su CH; Chiu HC; Tu RY; Lo YT; Chang YH; Lin HY; Lin SP
    Int J Med Sci; 2021; 18(15):3373-3379. PubMed ID: 34522163
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.
    Mesolella M; Cimmino M; Cantone E; Marino A; Cozzolino M; Della Casa R; Parenti G; Iengo M
    Acta Otorhinolaryngol Ital; 2013 Aug; 33(4):267-72. PubMed ID: 24043915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway.
    Gönüldaş B; Yılmaz T; Sivri HS; Güçer KŞ; Kılınç K; Genç GA; Kılıç M; Coşkun T
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):944-9. PubMed ID: 24731921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
    Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
    Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hearing loss and airway problems in children with mucopolysaccharidoses].
    Santos S; López L; González L; Domínguez MJ
    Acta Otorrinolaringol Esp; 2011; 62(6):411-7. PubMed ID: 21757178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENT and mucopolysaccharidoses.
    Bianchi PM; Gaini R; Vitale S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):127. PubMed ID: 30442170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review.
    Ruckenstein MJ; Macdonald RE; Clarke JT; Forte V
    J Otolaryngol; 1991 Jun; 20(3):177-83. PubMed ID: 1908026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otorhinolaryngological manifestations of the mucopolysaccharidoses.
    Simmons MA; Bruce IA; Penney S; Wraith E; Rothera MP
    Int J Pediatr Otorhinolaryngol; 2005 May; 69(5):589-95. PubMed ID: 15850680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ear, nose and throat disease profile in children with Down syndrome].
    Paul D MA; Bravo V A; Beltrán M C; Cerda L J; Angulo M D; Lizama C M
    Rev Chil Pediatr; 2015; 86(5):318-24. PubMed ID: 26342393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniosynostosis and ENT.
    Couloigner V; Ayari Khalfallah S
    Neurochirurgie; 2019 Nov; 65(5):318-321. PubMed ID: 31568777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses.
    Lin HY; Shih SC; Chuang CK; Lee KS; Chen MR; Lin HC; Chiu PC; Niu DM; Lin SP
    Mol Genet Metab; 2014 Apr; 111(4):533-8. PubMed ID: 24594444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transnasal adenoidectomy in mucopolysaccharidosis.
    Harrison R; Schaefer S; Warner L; Mercer J; Jones S; Bruce I
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():149-152. PubMed ID: 29958599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of otorhinolaryngological manifestations in patients with primary ciliary dyskinesia.
    Günaydın RÖ; Eroğlu E; Tellioğlu B; Emiralioğlu N; Özçelik HU; Yalçın E; Doğru D; Kiper EN
    Int J Pediatr Otorhinolaryngol; 2023 May; 168():111520. PubMed ID: 36990030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of ear, nose and throat disorders in preschool children with Down's syndrome in Glasgow.
    Barr E; Dungworth J; Hunter K; McFarlane M; Kubba H
    Scott Med J; 2011 May; 56(2):98-103. PubMed ID: 21670137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guideline: Tonsillectomy in Children (Update)-Executive Summary.
    Mitchell RB; Archer SM; Ishman SL; Rosenfeld RM; Coles S; Finestone SA; Friedman NR; Giordano T; Hildrew DM; Kim TW; Lloyd RM; Parikh SR; Shulman ST; Walner DL; Walsh SA; Nnacheta LC
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):187-205. PubMed ID: 30921525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory and sleep disorders in mucopolysaccharidosis.
    Berger KI; Fagondes SC; Giugliani R; Hardy KA; Lee KS; McArdle C; Scarpa M; Tobin MJ; Ward SA; Rapoport DM
    J Inherit Metab Dis; 2013 Mar; 36(2):201-10. PubMed ID: 23151682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of otorhinolaryngologic manifestations in children with mucopolysaccharide storage disease typeⅠand type Ⅱ].
    Bai X; Liu R; Feng S; Pu J; Gu Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):221-224;229. PubMed ID: 38433691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Otorhinolaryngo logical manifestations in patients with Down syndrome].
    Morales-Angulo C; Gallo-Terán J; Azuara N; Rama Quintela J
    Acta Otorrinolaringol Esp; 2006; 57(6):262-5. PubMed ID: 16872101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysomnographic characteristics in patients with mucopolysaccharidoses.
    Lin HY; Chen MR; Lin CC; Chen CP; Lin DS; Chuang CK; Niu DM; Chang JH; Lee HC; Lin SP
    Pediatr Pulmonol; 2010 Dec; 45(12):1205-12. PubMed ID: 20717914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of general and disease specific ENT problems in children with Epidermolysis Bullosa--a retrospective case note review.
    Hore I; Bajaj Y; Denyer J; Martinez AE; Mellerio JE; Bibas T; Albert D
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):385-91. PubMed ID: 17145082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.